Lead Product(s) : Colistin Sulfate
Therapeutic Area : Genetic Disease
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy
Details : Colistin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cystic Fibrosis.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 29, 2016
Lead Product(s) : Colistin Sulfate
Therapeutic Area : Genetic Disease
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
